OncoMatch/Clinical Trials/NCT04641247
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Is NCT04641247 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies Niraparib for ovarian neoplasms.
Treatment: Niraparib — This is a global extension study to provide continued access to niraparib and further characterize the long-term safety of niraparib treatment in participants who are currently receiving treatment with niraparib within GlaxoSmithKline/TESARO-sponsored studies (NCT01847274, NCT02354586, NCT01905592, NCT03308942, NCT02657889) that has fulfilled the requirements for the primary objective.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Targeted therapy
Cancer type
Ovarian Cancer
Breast Carcinoma
Prior therapy
Must have received: PARP inhibitor (niraparib) — parent GlaxoSmithKline/TESARO-sponsored study
currently receiving treatment with niraparib (as monotherapy or in combination) in a GlaxoSmithKline/TESARO-sponsored study that has fulfilled the requirements for the primary objective
Cannot have received: PARP inhibitor (niraparib)
has been permanently discontinued from niraparib treatment in the parent study for any reason
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- GSK Investigational Site · Tucson, Arizona
- GSK Investigational Site · Encinitas, California
- GSK Investigational Site · Los Angeles, California
- GSK Investigational Site · Whittier, California
- GSK Investigational Site · Jacksonville, Florida
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT04641247 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior PARP inhibitor disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages